These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34838586)

  • 1. Autoimmune consequences of biologics.
    Dhital R; Kavanaugh A
    J Allergy Clin Immunol; 2022 Jan; 149(1):48-50. PubMed ID: 34838586
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in the use of biologics in psoriasis and autoimmune disorders. The role of autoantibodies.
    Rott S; Mrowietz U
    BMJ; 2005 Mar; 330(7493):716-20. PubMed ID: 15790644
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologics in Inflammatory Immune-mediated Systemic Diseases.
    Moroncini G; Calogera G; Benfaremo D; Gabrielli A
    Curr Pharm Biotechnol; 2017; 18(12):1008-1016. PubMed ID: 29278213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics in autoimmune diseases.
    Shi G; Liu Y
    Curr Pharm Biotechnol; 2014; 15(6):509. PubMed ID: 25213358
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
    Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of biologics in the treatment of autoimmune liver disease.
    Chang C; Tanaka A; Bowlus C; Gershwin ME
    Expert Opin Investig Drugs; 2020 Apr; 29(4):385-398. PubMed ID: 32102572
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for the treatment of autoimmune renal diseases.
    Holdsworth SR; Gan PY; Kitching AR
    Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic immunomodulatory medications and autoimmune cytopenias: A cross-sectional analysis of a national surveillance database.
    Bibb LA; Adkins BD; Stephens LD; Booth GS; Jacobs JW
    J Am Acad Dermatol; 2024 Jul; 91(1):153-156. PubMed ID: 38513833
    [No Abstract]   [Full Text] [Related]  

  • 10. Thematic issue: Biologics in autoimmune diseases.
    Sciascia S; Cuadrado MJ
    Int Immunopharmacol; 2015 Aug; 27(2):179. PubMed ID: 25962817
    [No Abstract]   [Full Text] [Related]  

  • 11. Updates in the field of autoimmune pancreatitis: a clinical guide.
    de Pretis N; Amodio A; Frulloni L
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):705-709. PubMed ID: 29923430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unintended Immunological Consequences of Biologic Therapy.
    Henrickson SE; Ruffner MA; Kwan M
    Curr Allergy Asthma Rep; 2016 Jun; 16(6):46. PubMed ID: 27324478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.
    Tsao NW; Sayre EC; Hanley G; Sadatsafavi M; Lynd LD; Marra CA; De Vera MA
    Ann Rheum Dis; 2018 Jun; 77(6):869-874. PubMed ID: 29496718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences.
    Maniadakis N; Toth E; Schiff M; Wang X; Nassim M; Szegvari B; Mountian I; Curtis JR
    Adv Ther; 2018 Sep; 35(9):1333-1355. PubMed ID: 30078176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics in the treatment of skin and rheumatologic diseases.
    Kahlenberg JM; Billi AC; Eyerich K; Gudjonsson JE
    J Allergy Clin Immunol; 2020 Apr; 145(4):1138-1141. PubMed ID: 32112793
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologic agents in autoimmune diseases.
    Keystone EC; Strand V
    J Rheumatol; 1996 Apr; 23(4):743-6. PubMed ID: 8730137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of drugs to treat autoimmune disease - from biologics to small molecules].
    Muramoto K
    Nihon Yakurigaku Zasshi; 2013 Aug; 142(2):58-62. PubMed ID: 23934523
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.
    Jani M; Dixon WG; Chinoy H
    Rheumatology (Oxford); 2018 Nov; 57(11):1896-1907. PubMed ID: 29325166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and assessment of biological treatments for children.
    Smith EM; Foster HE; Beresford MW
    Br J Clin Pharmacol; 2015 Mar; 79(3):379-94. PubMed ID: 24750505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.